A novel multicenter preclinical drug screening and biomarker consortium for experimental traumatic brain injury: operation brain trauma therapy.
about
Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug CandidateRole of Microvascular Disruption in Brain Damage from Traumatic Brain InjuryThe Controlled Cortical Impact Model: Applications, Considerations for Researchers, and Future DirectionsExosome platform for diagnosis and monitoring of traumatic brain injuryProstaglandin F2α FP receptor antagonist improves outcomes after experimental traumatic brain injuryA novel rat model of blast-induced traumatic brain injury simulating different damage degree: implications for morphological, neurological, and biomarker changesRole of the prostaglandin E2 EP1 receptor in traumatic brain injurySerum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder.Determination of Serum Lost Goodwill Target Proteome in Patients with Severe Traumatic Brain InjuryLong-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological OutcomesA military-centered approach to neuroprotection for traumatic brain injury.Addressing the needs of traumatic brain injury with clinical proteomics.Bringing rigour to translational medicine.Phosphodiesterase inhibitors as therapeutics for traumatic brain injury.Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker.Effects of early rolipram treatment on histopathological outcome after controlled cortical impact injury in mice.Mortality and Associated Morbidities Following Traumatic Brain Injury in Older Medicare Statin Users.In-Hospital Mortality Following Traumatic Brain Injury Among Older Medicare Beneficiaries, Comparing Statin Users With Nonusers.Multi-Center Pre-clinical Consortia to Enhance Translation of Therapies and Biomarkers for Traumatic Brain Injury: Operation Brain Trauma Therapy and Beyond
P2860
Q26782938-FE627344-45FC-4004-A2DA-D44D59533157Q27009187-93CBFFFA-AAD5-4776-AF13-2C535E442DF1Q28067060-71ECB7DC-ADD5-466D-898A-3ABEBBA22648Q28246267-AD59313A-9EAB-498A-BFF8-4BE77F015E27Q30570103-D9175B10-3449-4221-BBE2-24C3D0FC447EQ30646172-FCBD785F-52A2-4485-A02A-2B40C91F848DQ34576460-67D05EB6-2F0D-4C4A-B274-A3B1B7436C9DQ36079583-BEEF8426-57D6-4B60-AC92-EA23A349105DQ36144992-6BDEA8C6-4B5C-4886-A548-48F6180E2B00Q36366723-E84C65CB-B6D2-4471-8B69-6371FC1FBC54Q36920836-E120D1E4-4889-45C6-B41F-C806616AB1BAQ37685775-F5D5827A-AF56-43E6-8F23-1EF49431D385Q38163820-ED9AC409-0BC2-4AA6-BEE3-E5D6931717F0Q38243490-56CDBEBE-4FF5-4B70-8B50-16B81521FF34Q38480577-D10B4EEA-4E0D-4FD4-A6F5-C9D3B980CE92Q42424556-3DD3D2CE-98D0-40B3-8F1A-8B9323D84E1AQ47554315-090ED7BA-47EA-46F1-BFB9-4D0094A6422AQ55218190-02BBC8BB-7BD2-4BFE-830F-12121C83A04DQ57170404-24368DD5-A555-4835-8A78-320CF412D476
P2860
A novel multicenter preclinical drug screening and biomarker consortium for experimental traumatic brain injury: operation brain trauma therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A novel multicenter preclinica ...... peration brain trauma therapy.
@en
A novel multicenter preclinica ...... peration brain trauma therapy.
@nl
type
label
A novel multicenter preclinica ...... peration brain trauma therapy.
@en
A novel multicenter preclinica ...... peration brain trauma therapy.
@nl
prefLabel
A novel multicenter preclinica ...... peration brain trauma therapy.
@en
A novel multicenter preclinica ...... peration brain trauma therapy.
@nl
P2093
P921
P1433
P1476
A novel multicenter preclinica ...... peration brain trauma therapy.
@en
P2093
C Edward Dixon
Frank C Tortella
Helen Bramlett
John Povlishock
Ronald L Hayes
W Dalton Dietrich
P304
P356
10.1097/TA.0B013E31822117FE
P407
P433
P577
2011-07-01T00:00:00Z